Related Experiment Videos
Altered aquaporin-4 expression in human muscular dystrophies: a common feature?
Antonio Frigeri1, Grazia Paola Nicchia, Silvia Repetto
1Dipartimento di Fisiologia Generale ed Ambientale and Centro di Eccellenza in Genomica Comparata, Università degli Studi di Bari, I-70126 Bari, Italy. a.frigeri@biologia.uniba.it
Abstract:
Duchenne Muscular Dystrophy (DMD) is a progressive lethal muscle disease that affects young boys. Dystrophin, absent in DMD and reduced in the milder form Becker Muscular Dystrophy (BMD), binds to several membrane-associated proteins known as dystrophin-associated proteins (DAPs). Once this critical structural link is disrupted, muscle fibers become more vulnerable to mechanical and osmotic stress. Recently, we have reported that the expression of aquaporin-4 (AQP4), a water-selective channel expressed in the sarcolemma of fast-twitch fibers and astrocyte end-feet, is drastically reduced in the muscle and brain of the mdx mouse, the animal model of DMD. In the present study, we analyzed the expression of AQP4 in several DMD/BMD patients of different ages with different mutations in the dystrophin gene. Immunofluorescence results indicate that, compared with healthy control children, AQP4 is reduced severely in all the DMD muscular biopsies analyzed and in 50% of the analyzed BMD. Western blot analysis revealed that the deficiency in sarcolemma AQP4 staining is due to a reduction in total AQP4 muscle protein content rather than to changes in immunoreactivity. Double-immunostaining experiments indicate that AQP4 reduction is independent of changes in the fiber myosin heavy chain composition. AQP4 and a-syntrophin analysis of BMD muscular biopsies revealed that the expression and stability of AQP4 in the sarcolemma does not always decrease when a-syntrophin is strongly reduced. Finally, limb-girdle muscular dystrophy biopsies and facioscapulohumeral muscular dystrophy revealed that AQP4 expression was not altered in these forms of muscular dystrophy. These experiments provide the first evidence of AQP4 reduction in a human pathology and show that this deficiency is an important feature of DMD/BMD.
Insights
Aquaporin-4 (AQP4) water channels are severely reduced in Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) patients. This deficiency in AQP4 protein content is a key feature of these progressive muscle-wasting diseases.
Area of Science:
- Muscle physiology
- Molecular biology
- Biochemistry
Background:
- Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) result from dystrophin deficiency, disrupting the sarcolemma's structural integrity.
- Aquaporin-4 (AQP4), a water channel in muscle fibers, is known to be reduced in mdx mice, an animal model for DMD.
- The role and expression of AQP4 in human DMD and BMD patients remain largely uncharacterized.
Purpose of the Study:
- To investigate the expression levels of AQP4 in muscle biopsies from patients with DMD and BMD.
- To determine if AQP4 reduction is a common feature across different dystrophinopathies and specific mutations.
- To explore the relationship between AQP4 expression, protein content, and other sarcolemmal components.
Main Methods:
- Immunofluorescence and Western blot analyses were performed on muscle biopsies from DMD, BMD, and healthy control individuals.
- Expression levels of AQP4 were quantified and compared across patient groups.
- Double-immunostaining was used to assess AQP4 localization and its independence from fiber type.
- Analysis of AQP4 and alpha-syntrophin co-expression in BMD biopsies.
Main Results:
- AQP4 expression was found to be severely reduced in all analyzed DMD biopsies and in 50% of BMD biopsies.
- The reduction in AQP4 was attributed to decreased total muscle protein content, not altered immunoreactivity.
- AQP4 reduction was independent of muscle fiber myosin heavy chain composition.
- In BMD, AQP4 levels did not always decrease proportionally with alpha-syntrophin reduction.
Conclusions:
- This study provides the first evidence of AQP4 reduction in human muscular dystrophies.
- Reduced AQP4 protein content is a significant pathological feature in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
- AQP4 deficiency may contribute to the pathophysiology of DMD and BMD, independent of fiber type and alpha-syntrophin levels.